312 related articles for article (PubMed ID: 34566866)
1. MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
Clarke L; Arnett S; Bukhari W; Khalilidehkordi E; Jimenez Sanchez S; O'Gorman C; Sun J; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Abernethy DA; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Fabis-Pedrini MJ; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Ramanathan S; Reddel SW; Shaw CP; Spies JM; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AGK; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Brilot F; Vincent A; Waters P; Broadley SA
Front Neurol; 2021; 12():722237. PubMed ID: 34566866
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Clarke L; Arnett S; Lilley K; Liao J; Bhuta S; Broadley SA
Clin Exp Immunol; 2021 Dec; 206(3):251-265. PubMed ID: 34080180
[TBL] [Abstract][Full Text] [Related]
3. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder.
Cai MT; Zheng Y; Shen CH; Yang F; Fang W; Zhang YX; Ding MP
Mult Scler; 2021 May; 27(6):871-882. PubMed ID: 32672091
[TBL] [Abstract][Full Text] [Related]
5. Modified models to distinguish central nervous system demyelinating diseases with brain lesions.
Chen B; Qin C; Ji S; Tian D; Zhang M; Bu B
Mult Scler Relat Disord; 2021 Jul; 52():102965. PubMed ID: 33905981
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy.
Rabasté S; Cobo-Calvo A; Nistiriuc-Muntean V; Vukusic S; Marignier R; Cotton F;
J Neuroradiol; 2021 Feb; 48(1):28-36. PubMed ID: 32407908
[TBL] [Abstract][Full Text] [Related]
7. Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.
Sechi E; Krecke KN; Messina SA; Buciuc M; Pittock SJ; Chen JJ; Weinshenker BG; Lopez-Chiriboga AS; Lucchinetti CF; Zalewski NL; Tillema JM; Kunchok A; Monaco S; Morris PP; Fryer JP; Nguyen A; Greenwood T; Syc-Mazurek SB; Keegan BM; Flanagan EP
Neurology; 2021 Sep; 97(11):e1097-e1109. PubMed ID: 34261784
[TBL] [Abstract][Full Text] [Related]
8. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
9. Brain lesion distribution criteria distinguish demyelinating diseases in China.
Cai MT; Zhang YX; Zheng Y; Yang F; Fang W; Shen CH; Ding MP
Ann Clin Transl Neurol; 2019 Oct; 6(10):2048-2053. PubMed ID: 31566925
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
Liao MF; Chang KH; Lyu RK; Huang CC; Chang HS; Wu YR; Chen CM; Chu CC; Kuo HC; Ro LS
BMC Neurol; 2014 Nov; 14():218. PubMed ID: 25433369
[TBL] [Abstract][Full Text] [Related]
11. Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis.
Raz E; Loh JP; Saba L; Omari M; Herbert J; Lui Y; Kister I
Mult Scler Int; 2014; 2014():986923. PubMed ID: 24665366
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
13. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
[TBL] [Abstract][Full Text] [Related]
14. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic performance of AI-based algorithms to discriminate between NMOSD and MS using MRI features: A systematic review and meta-analysis.
Etemadifar M; Norouzi M; Alaei SA; Karimi R; Salari M
Mult Scler Relat Disord; 2024 Jul; 87():105682. PubMed ID: 38781885
[TBL] [Abstract][Full Text] [Related]
16. Pruritus in neuromyelitis optica spectrum disorders and multiple sclerosis.
He M; Wu L; Huang D; Yau V; Yu S
J Clin Neurosci; 2020 Sep; 79():108-112. PubMed ID: 33070876
[TBL] [Abstract][Full Text] [Related]
17. The pathologic and diagnostic in magnetic resonance imaging of brain and cervical spine of patients with neuromyelitis optica spectrum disorder.
Mehdipour-Dastjerdi R; Ashtari F; Shaygannejad V; Mansourian M; Safaei A
Iran J Neurol; 2018 Apr; 17(2):58-63. PubMed ID: 30210729
[No Abstract] [Full Text] [Related]
18. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
19. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
[TBL] [Abstract][Full Text] [Related]
20. MRI differences between MOG antibody disease and AQP4 NMOSD.
Salama S; Khan M; Shanechi A; Levy M; Izbudak I
Mult Scler; 2020 Dec; 26(14):1854-1865. PubMed ID: 31937191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
